State Street’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

State Street’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,600	Closed	-$422K	–	3700
2016 Q4	$422K	Buy	+11,600	New	+$410K	﹤0.01%	3414

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

State Street's CLCD Position: Q1 2017 in Review

State Street sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 11,600 shares — an estimated $422K sold.

State Street first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $422K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

State Street reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
State Street sold 11,600 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $422K.
State Street first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
State Street's CoLucid Pharmaceuticals, Inc. position peaked at $422K in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on State Street's 13F filing for Q1 2017, filed 15 May 2017.